JoffresMGhadirianPFodorJ. Awareness, treatment and control of hypertensionIn Canada. Am J Hypertens1997;10:1097–102
2.
Swanson-FisherRWCloverK. Compliance in the treatment of hypertension: a need for actionAm J Hypertens1995;8:82S–88S
3.
JonesJKGorkinLLianJF. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom populationBMJ1995;311:293–5
4.
MarentetteMGerthWBillingsDZarnkeK. Antihypertensive persistence and drug classCan J Cardiol2002;18(6):649–56
5.
CaroJSpeckmanJSalasM. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice dataCMAJ1999;160:41–6
6.
DickinsonDRaynorDKT. Ask the patients — they may want to know more than you thinkBMJ2003;327:861–2
7.
DeschampsMDyckATaylorJ. What are we saying? Content and organization of patient counseling by community pharmacistsCan Pharm J2003;236(6):42–7
8.
EvansSWJohnDN. A preliminary investigation of the interactions between UK and US community pharmacists and their prescription clientsInt J Pharm Pract1995;3:157–62
9.
BarnettCNykampDEllingtonA. Patient-guided counseling in the community pharmacy settingJ Am Pharm Assoc2000;40:765–72
10.
McAlisterFALaupacisA. Towards a better yardstick: the choice of treatment thresholds in hypertensionCan J Cardiol1998;14:47–51